|
KIF2C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.10702591327572E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.46250000000603E-05 |
| Normal-vs-Stage2 |
3.131500E-02 |
| Normal-vs-Stage3 |
4.38470000000413E-05 |
| Normal-vs-Stage4 |
1.394360E-02 |
| Stage1-vs-Stage2 |
4.208800E-01 |
| Stage1-vs-Stage3 |
9.198800E-04 |
| Stage1-vs-Stage4 |
3.861000E-03 |
| Stage2-vs-Stage3 |
1.166450E-01 |
| Stage2-vs-Stage4 |
1.007390E-01 |
| Stage3-vs-Stage4 |
5.925000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54150026077104E-10 |
| Normal-vs-AfricanAmerican |
7.52640000000193E-05 |
| Normal-vs-Asian |
5.679500E-02 |
| Caucasian-vs-AfricanAmerican |
6.400200E-01 |
| Caucasian-vs-Asian |
2.854200E-01 |
| AfricanAmerican-vs-Asian |
1.359810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.26907381772889E-12 |
| Normal-vs-Female |
3.80500000000117E-05 |
| Male-vs-Female |
3.150400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.369700E-04 |
| Normal-vs-Extreme_Weight |
1.81860000003642E-06 |
| Normal-vs-Obese |
1.25439999998367E-06 |
| Normal-vs-Extreme_Obese |
1.704480E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.237030E-01 |
| Normal_Weight-vs-Obese |
9.751600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.582000E-02 |
| Extreme_Weight-vs-Obese |
5.502200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.024790E-01 |
| Obese-vs-Extreme_Obese |
2.575500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.960600E-03 |
| Normal-vs-Age(41-60Yrs) |
8.79750050586381E-10 |
| Normal-vs-Age(61-80Yrs) |
1.56075999999672E-05 |
| Normal-vs-Age(81-100Yrs) |
3.025600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.725800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.716000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.712320E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.136000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.387600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.540980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.95700028299473E-10 |
| Normal-VS-Type2 PRCC |
1.72296999999544E-05 |
| Normal-VS-KIRP CIMP |
7.621700E-04 |
| Normal-VS-Unclassified PRCC |
1.636580E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.397600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.962280E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.946400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.36880000004103E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
8.147200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.883000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.16450000000746E-05 |
| Normal-vs-N1 |
2.42530000005292E-06 |
| Normal-vs-N2 |
1.325830E-01 |
| N0-vs-N1 |
4.170800E-04 |
| N0-vs-N2 |
2.602600E-01 |
| N1-vs-N2 |
8.098200E-01 |
|
|
